Nobeglar (100 IU/ml) (1*5ml Vial) Solution For Injection 5ml

Nobeglar 100 Iu Ml 1 5ml Vial Solution For Injection 5ml is a long‑acting recombinant human insulin analogue used to manage high blood sugar in adults and children with diabetes mellitus. It provides a steady level of insulin for about 24 hours, mimicking the body’s natural background insulin release. This helps regulate glucose levels between meals and overnight. It is indicated for both Type 1 and Type 2 diabetes and is given by subcutaneous injection. It is available in pre‑filled pens, cartridges, and vials.

Nobeglar 100 Iu Ml 1 5ml Vial Solution For Injection 5ml is a long-acting insulin analogue used to help manage blood sugar levels in people with diabetes mellitus. It is designed to provide a steady, baseline level of insulin activity over approximately 24 hours or longer, with minimal peaks and troughs. This makes it useful for maintaining consistent glucose control throughout the day and night, reducing the risk of sudden fluctuations in blood sugar. It is commonly prescribed for both type 1 diabetes, where it is used alongside rapid-acting insulin for mealtime coverage, and type 2 diabetes, where it may be added when oral medications are not sufficient.

The medication works by mimicking the natural hormone insulin, which helps move glucose from the bloodstream into tissues such as muscle and fat, while also reducing glucose production in the liver. Insulin glargine is formulated to be less soluble at physiological pH, so after injection under the skin it forms microprecipitates that slowly release insulin into the bloodstream. This unique mechanism ensures a prolonged and stable effect, allowing for once-daily dosing in most patients.

Proper education on injection technique and site rotation is essential to reduce the risk of local tissue changes such as lipodystrophy. For safe use, you are advised to follow your doctor’s instructions closely, monitor blood sugar regularly, and maintain a balanced diet and lifestyle as part of an overall diabetes management plan.

Nobeglar 100 Iu Ml 1 5ml Vial Solution For Injection 5ml may be indicated by your doctor for:

Type 1 Diabetes Mellitus

As part of a basal–bolus insulin regimen to provide steady background insulin and help control blood sugar throughout the day and night.

Type 2 Diabetes Mellitus

When oral medicines, diet, and exercise are not enough to maintain blood sugar control, insulin glargine may be added to improve fasting glucose and overall glycemic management.

Prevention of Diabetes Complications

By maintaining stable blood glucose levels, insulin glargine helps reduce the risk of long-term complications such as nerve damage, kidney disease, eye problems, and cardiovascular issues.

Nobeglar 100 Iu Ml 1 5ml Vial Solution For Injection 5ml may provide benefits such as:

• Consistent Glycemic Control: Provides a stable, long-acting insulin effect for approximately 24 hours, helping to maintain steady blood glucose levels without pronounced peaks.

• Reduced Risk of Hypoglycemia: Its flat pharmacokinetic profile lowers the likelihood of sudden drops in blood sugar, particularly during nighttime hours.

• Simplified Treatment Regimen: Typically administered once daily, which improves adherence and convenience compared to multiple daily injections of shorter-acting insulins.

• Prevention of Long-Term Complications: By supporting sustained glucose control, insulin glargine contributes to reducing the risk of diabetes-related complications such as neuropathy, nephropathy, retinopathy, and cardiovascular disease.

Nobeglar 100 Iu Ml 1 5ml Vial Solution For Injection 5ml may cause side effects, although not everyone will experience them. Most reactions are mild and temporary, but some can be more severe and require medical attention.

Common side effects of Nobeglar 100 Iu Ml 1 5ml Vial Solution For Injection 5ml may include

• Hypoglycemia (low blood sugar)

• Injection site reactions (redness, pain, or swelling)

• Lipodystrophy (thickening or pitting of the skin at the injection site)

• Weight gain

• Oedema (swelling in the hands or ankles)

Uncommon side effects of Nobeglar 100 Iu Ml 1 5ml Vial Solution For Injection 5ml may include

• Pruritus (itching) or rash

• Visual disturbances (temporary)

Serious side effects that may require immediate medical attention include

• Severe hypoglycemia (confusion, seizures, or loss of consciousness)

• Hypokalemia (low potassium levels in the blood, causing muscle weakness or heart rhythm issues)

• Signs of a severe allergic reaction (generalised rash, shortness of breath, or fast pulse)

• Always consult your doctor if you notice any unusual or concerning symptoms while using Nobeglar 100 Iu Ml 1 5ml Vial Solution For Injection 5ml.

Use Nobeglar 100 Iu Ml 1 5ml Vial Solution For Injection 5ml exactly as prescribed by your doctor. It is a long-acting insulin given once daily at the same time each day. Use it for injection under the skin (subcutaneous) only.

Preparation and administration:

Check the insulin before use. It should be clear and colourless. Do not use it if it looks cloudy or contains particles.

If using a pre-filled pen, attach a new needle and prime the pen by dialling 2 units until insulin appears. Set your prescribed dose. Inject under the skin at a 90° angle, preferably in the abdomen, thigh, or upper arm. Press the button fully and hold for about 10 seconds before removing the needle to ensure the full dose is delivered.

Do not mix this insulin with other insulins. Do not inject into a vein or muscle. Rotate the injection site each time to help prevent skin changes such as lipodystrophy.

Storage and safety:

Store unopened insulin in a refrigerator (2°C–8°C). Do not freeze.

Once in use, you may keep it at room temperature. Discard it after 4 weeks, even if some insulin remains.

Do not share pens or needles with others, even if the needle is changed.

Monitor your blood sugar levels regularly, as advised by your doctor.

Nobeglar 100 Iu Ml 1 5ml Vial Solution For Injection 5ml works by regulating glucose metabolism. It binds to insulin receptors on muscle and fat cells, facilitating the uptake of glucose from the blood into the cells for energy. It also inhibits the liver from producing and releasing more glucose. Because Nobeglar 100 Iu Ml 1 5ml Vial Solution For Injection 5ml is less soluble at neutral pH, it forms a depot after injection that releases the insulin slowly, providing a consistent glucose-lowering effect over 24 hours.

• Always carry a fast-acting carbohydrate source (like glucose tablets or candy) to treat sudden low blood sugar.

• Never share your insulin pen or needle with others, even if the needle is changed, to avoid the risk of infection.

• If you are ill, your insulin needs may increase; continue monitoring your glucose levels closely and contact your doctor.

• Check your skin for "lumps" or thickening; rotating your injection site daily helps prevent these issues.

• Unopened (Vials/Pens): Store in the refrigerator (2°C to 8°C). Do not freeze. Keep away from the cooling element.

• Opened (In-use): Store at room temperature (up to 30°C) or in the refrigerator for the duration specified by the manufacturer (usually 28 days).

• Protect from direct heat and light. Do not use insulin that has been frozen.

• Store safely out of the reach of children.

• Alcohol (CAUTION): Can intensify the glucose-lowering effect and mask the warning signs of hypoglycemia.

• Large/Delayed Meals (CAUTION): May cause fluctuations in blood sugar if not balanced with your insulin schedule.

• Beta-blockers (MODERATE): May mask the heart rate increases that warn you of low blood sugar.

• Steroids/Corticosteroids (CAUTION): Can raise blood sugar levels, requiring an increase in insulin dose.

• Thiazolidinediones/TZDs (CAUTION): May cause fluid retention and worsen heart failure when used with insulin.

• Hypokalemia (CAUTION): Insulin can lower potassium levels; use with care in patients predisposed to low potassium.

• Heart Failure (CAUTION): Use of certain oral diabetes drugs (TZDs) with insulin can increase the risk of heart failure and oedema.

• Renal/Hepatic Impairment (CAUTION): May require more frequent dose adjustments and monitoring.

An overdose of Nobeglar 100 Iu Ml 1 5ml Vial Solution For Injection 5ml can lead to severe hypoglycemia, which is life-threatening. Symptoms include extreme weakness, blurred vision, sweating, trouble speaking, tremors, and confusion. If you suspect an overdose, consume a fast-acting sugar source (like glucose gel or fruit juice) and seek emergency medical assistance immediately.

If you forget your dose, take it as soon as you remember. However, if it is nearly time for your next dose, skip the missed dose and continue with your regular schedule. Do not take two doses at once. Consult your doctor if you are unsure how to proceed.